Table 1. Baseline characteristics of metastatic prostate cancer patients whose images were used for the survival analysis.
| Variables | Values (N = 207) | |
|---|---|---|
| Age, yr | 70.9 ± 8.9 | |
| With HTN | 71 (34.3) | |
| With DM | 44 (21.3) | |
| No. of bone metastasis | ||
| ≤ 10 | 85 (41.1) | |
| > 10 | 122 (58.9) | |
| T stage | ||
| T2 | 57 (27.5) | |
| T3–4 | 175 (84.5) | |
| ISUP GG | ||
| GG1–3 | 32 (15.5) | |
| GG4–5 | 175 (84.5) | |
| PSA at ADT initiation | 278 (101–657) | |
| LN metastasis | 141 (68.1) | |
| Visceral metastasis | 35 (16.9) | |
Values are presented as number (%), mean ± standard deviation, or median (interquartile range).
HTN = hypertension, DM = diabetes mellitus, ISUP GG = International Society of Urological Pathology Grade Group, PSA = prostate-specific antigen, ADT = androgen deprivation therapy, LN = lymph node.